Eckert & Ziegler Increases Dividend

14:58 EDT 26 Mar 2019 | EQS Group

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Annual Results
Eckert & Ziegler Increases Dividend

26-March-2019 / 18:58 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Berlin, 26 March 2019. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope-based applications in medicine, science and industry achieved sales of approx. 168.7 million EUR in the fiscal year 2018. As the Supervisory Board stated at its balance sheet meeting, the net profit was 16.1 million EUR or 3.12 EUR per share. For the fiscal year 2019, a net profit of about EUR 18 million is expected.

At the General Shareholders' Meeting to be held on 29 May 2019, the Executive Board and the Supervisory Board will propose a dividend of 1.20 EUR per share entitled to a dividend (previous year: 0.80 EUR per share).

The complete figures for the FY 2018 will be published on 5 April 2019.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138,,

26-March-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

Original Article: Eckert & Ziegler Increases Dividend


More From BioPortfolio on "Eckert & Ziegler Increases Dividend"

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...